Insiders Cantargia AB

Equities

Market Closed - Nasdaq Stockholm Other stock markets 11:29:48 2024-05-14 EDT			5-day change	1st Jan Change
3.584 ^SEK	-1.81%		-0.72%	-4.12%

04-17	Cantargia Publishes New Data on the Can10 Antibody, Detailing Its Interaction with IL1RAP and Functional Inhibition	CI
04-10	Cantargia AB Publishes Preclinical Data on the Potential of CAN10 in Systemic Sclerosis in A Leading Scientific Journal	CI

Cantargia AB Promotes David Liberg to Chief Scientific Officer	23-06-01	CI
Cantargia : The nomination committees statement	23-04-24	PU
Cantargia Appoints Patrik Renblad as Chief Financial Officer	23-02-01	CI
Cantargia AB Announces Nomination Committee Appointments	22-11-21	CI
Nomination Committee appointed ahead of 2023 Annual General Meeting	22-11-21	AQ
Cantargia AB Announces Executive Changes	22-07-08	CI
Cantargia AB Strengthens Executive Management in Preparation for Late-Stage Clinical Development	22-03-10	CI
(R) Nomination Committee appointed ahead of 2022 Annual General Meeting	21-10-29	PU
Nomination Committee appointed ahead of 2022 Annual General Meeting	21-10-29	AQ
Cantargia AB Announces Appointment of Nomination Committee	21-10-29	CI
Cantargia AB Elect Magnus Nilsson and Damian Marron as New Board Members	21-05-26	CI
Cantargia AB Announces Claus Asbjørn Andersson Declined Re-Election	21-04-27	CI
Cantargia : Changes to Cantargia’s nomination committee	20-12-21	PU
Cantargia : Changes to Cantargia's nomination committee	20-12-21	AQ
Cantargia AB Announces Nomination Committee Changes	20-12-21	CI
Cantargia AB Announces Executive Changes	20-10-20	CI
Cantargia : Nomination Committee appointed ahead of 2021 Annual General Meeting	20-10-20	PU
Cantargia : Nomination Committee appointed ahead of 2021 Annual General Meeting	20-10-20	AQ
Cantargia : Cantargia’s nomination committee proposes a new board member	20-09-21	PU
Cantargia : nomination committee proposes a new board member	20-09-21	AQ

No results for this search